Significant ETF Withdrawals Observed - IYH, UNH, HCA, ELV
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 17 2025
0mins
Source: NASDAQ.COM
52-Week Range of IYH: IYH's share price has a 52-week low of $53.35 and a high of $66.91, with the last trade recorded at $64.81.
Understanding ETFs: Exchange traded funds (ETFs) function like stocks, where investors buy and sell "units" that can be created or destroyed based on demand.
Monitoring ETF Flows: Weekly monitoring of shares outstanding helps identify ETFs with significant inflows (new units created) or outflows (units destroyed), impacting the underlying holdings.
Disclaimer: The views expressed in the article are those of the author and do not necessarily represent Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 382.480
Low
330.00
Averages
397.82
High
444.00
Current: 382.480
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UnitedHealth Group Shares Set to Rebound After Six-Day Loss
- Stock Rebound: UnitedHealth Group (UNH) shares rose 1.6% to $388.9 on Friday, poised to end a six-day losing streak during which the stock fell over 4%, indicating market optimism for recovery despite recent volatility.
- Year-to-Date Performance: So far this year, UNH shares have increased nearly 17%, outperforming the S&P 500's 9% rise, although May has been neutral with seven up days and eight down days, reflecting mixed investor sentiment.
- Analyst Ratings: Seeking Alpha's Quant Rating gives UNH a hold score of 3.48, indicating strong profitability prospects (A+) but a concerning growth factor (F), with 22 analysts recommending buy, suggesting confidence in the stock's potential despite growth concerns.
- Financial Results: In April, UnitedHealth reported first-quarter revenue of $111.7 billion, up 2% year-over-year and exceeding estimates, with adjusted EPS of $7.23 beating expectations by $0.63, while raising its 2026 adjusted EPS outlook to over $18.25, highlighting robust earnings and positive future outlook.
See More
UnitedHealth Group's AI Technology Fuels Stock Recovery
- AI Chatbot Launch: UnitedHealth Group introduced a generative AI chatbot named Avery in March, designed to coordinate healthcare experiences for members, currently serving 6.5 million employer-sponsored plan members, with plans to expand to over 20 million by year-end, significantly enhancing customer satisfaction and service efficiency.
- Strong Stock Recovery: Since the announcement of the Avery system, UnitedHealth's stock has surged 53% over the past two months, reflecting positive market sentiment towards its AI adoption and bolstered by the company's first-quarter financial results that exceeded Wall Street expectations.
- Reduced Medical Benefit Ratio: The company reported a decrease in its medical benefit ratio to 83.9%, down from 84.8% a year ago and below the 85.5% expected by analysts, indicating significant progress in reducing operational costs and improving profitability through the application of AI tools.
- Future Investment Plans: UnitedHealth plans to invest an additional $1.6 billion in AI technology this year, aiming to further streamline healthcare processes and reduce administrative waste, a strategy that will provide greater growth potential in the competitive health insurance market.
See More
Greg Abel's First Quarter Report Reveals Investment Strategy
- Portfolio Adjustments: In his first quarterly report, Abel adjusted the $330 billion equity portfolio by adding positions in Delta Airlines and Macy's, while tripling the stake in Alphabet, indicating his proactive approach to high-conviction stocks while maintaining Buffett's investment style.
- Small Position Sell-Off: In the first quarter, Abel and his team sold out of 16 smaller positions, including Visa and Mastercard, which accounted for about a third of Berkshire's total holdings, demonstrating decisive action in optimizing the investment portfolio.
- Core Holdings Retained: Despite the significant sell-off, Abel retained core holdings such as Apple, American Express, and Coca-Cola, reflecting his respect for and continuation of the company's traditional investment strategies established by Buffett.
- Positive Market Reaction: Following the announcement of Abel's investment strategy, Berkshire Hathaway's stock ticked higher, reflecting market confidence in his management capabilities and further solidifying the company's position in the investment community.
See More
Berkshire Hathaway's Abel Restructures Equity Portfolio
- Portfolio Restructuring: Greg Abel cut 16 small positions in the first quarter, including long-held Visa and Mastercard, demonstrating a strategic focus on concentrated high-conviction stocks while maintaining Buffett's traditional investment style.
- New Investment Directions: Abel added positions in Delta Airlines and Macy's, and tripled the investment in Alphabet, indicating a strategy aligned with Buffett's tech stock preferences, which may attract younger investors.
- Increased Concentration: Excluding investments in Japan, Berkshire now holds only 29 positions, retaining Buffett favorites like Apple, American Express, and Coca-Cola, reflecting ongoing confidence in classic quality assets.
- Positive Market Reaction: Despite the reduction of about one-third of the portfolio, Berkshire's stock price rose following the announcement, indicating market approval of Abel's investment strategy and suggesting optimistic expectations for future performance.
See More
Healthcare Stocks Surge Due to Innovation and Policy Changes
- Strong Sector Performance: The healthcare sector has shown remarkable performance, with the State Street Health Care Select Sector SPDR ETF (XLV) rising 3.3% over the past week, significantly outperforming the S&P 500's 0.5% gain, indicating a robust rebound and renewed investor confidence in healthcare stocks.
- Drug Innovation Driving Prices: Merck (MRK) saw a substantial stock price increase after announcing a lung cancer drug that reduced tumor progression risk by 65% in a Phase 3 study, highlighting the positive impact of ongoing pharmaceutical innovation on stock valuations.
- Favorable Medicare Policies: The Centers for Medicare and Medicaid Services announced that starting in 2027, Eli Lilly's (LLY) GLP-1 drugs will be available to Medicare patients for $50 a month, resulting in a 25% stock price increase for Lilly over three weeks, demonstrating the direct support of policy changes for healthcare stocks.
- Aging Population Trend: The global aging population is driving increased demand for pharmaceuticals, medical devices, and health insurance, positioning the healthcare sector as a focal point for investors seeking growth opportunities in the face of demographic shifts.
See More
Healthcare Sector Sees Best Week in Six Months
- Strong Sector Performance: The State Street Health Care Select Sector SPDR ETF (XLV) rose 3.3% over the past five trading days, significantly outperforming the S&P 500's 0.5% gain, establishing healthcare as the top-performing sector this week and reflecting strong investor confidence in the industry.
- Pharmaceutical Innovation: Merck (MRK) saw its stock rise 5.63% this week after announcing a 65% reduction in tumor progression risk from a lung cancer drug developed with a Chinese partner in a Phase 3 study, highlighting the ongoing innovation within the pharmaceutical sector.
- Favorable Insurance Policies: The Centers for Medicare and Medicaid Services announced that Eli Lilly's (LLY) GLP-1 drugs will be available to Medicare patients for $50 a month starting January 2027, leading to a 25% stock price increase for Lilly over three weeks, showcasing the positive impact of policy changes on company performance.
- Aging Population Trend: The global aging population is driving increased demand for pharmaceuticals and medical services, positioning the healthcare sector for robust growth and attracting investors to healthcare ETFs as a safer investment choice amid economic uncertainties.
See More
UnitedHealth Group Shares Set to Rebound After Six-Day Loss
- Stock Rebound: UnitedHealth Group (UNH) shares rose 1.6% to $388.9 on Friday, poised to end a six-day losing streak during which the stock fell over 4%, indicating market optimism for recovery despite recent volatility.
- Year-to-Date Performance: So far this year, UNH shares have increased nearly 17%, outperforming the S&P 500's 9% rise, although May has been neutral with seven up days and eight down days, reflecting mixed investor sentiment.
- Analyst Ratings: Seeking Alpha's Quant Rating gives UNH a hold score of 3.48, indicating strong profitability prospects (A+) but a concerning growth factor (F), with 22 analysts recommending buy, suggesting confidence in the stock's potential despite growth concerns.
- Financial Results: In April, UnitedHealth reported first-quarter revenue of $111.7 billion, up 2% year-over-year and exceeding estimates, with adjusted EPS of $7.23 beating expectations by $0.63, while raising its 2026 adjusted EPS outlook to over $18.25, highlighting robust earnings and positive future outlook.
See More
UnitedHealth Group's AI Technology Fuels Stock Recovery
- AI Chatbot Launch: UnitedHealth Group introduced a generative AI chatbot named Avery in March, designed to coordinate healthcare experiences for members, currently serving 6.5 million employer-sponsored plan members, with plans to expand to over 20 million by year-end, significantly enhancing customer satisfaction and service efficiency.
- Strong Stock Recovery: Since the announcement of the Avery system, UnitedHealth's stock has surged 53% over the past two months, reflecting positive market sentiment towards its AI adoption and bolstered by the company's first-quarter financial results that exceeded Wall Street expectations.
- Reduced Medical Benefit Ratio: The company reported a decrease in its medical benefit ratio to 83.9%, down from 84.8% a year ago and below the 85.5% expected by analysts, indicating significant progress in reducing operational costs and improving profitability through the application of AI tools.
- Future Investment Plans: UnitedHealth plans to invest an additional $1.6 billion in AI technology this year, aiming to further streamline healthcare processes and reduce administrative waste, a strategy that will provide greater growth potential in the competitive health insurance market.
See More
Greg Abel's First Quarter Report Reveals Investment Strategy
- Portfolio Adjustments: In his first quarterly report, Abel adjusted the $330 billion equity portfolio by adding positions in Delta Airlines and Macy's, while tripling the stake in Alphabet, indicating his proactive approach to high-conviction stocks while maintaining Buffett's investment style.
- Small Position Sell-Off: In the first quarter, Abel and his team sold out of 16 smaller positions, including Visa and Mastercard, which accounted for about a third of Berkshire's total holdings, demonstrating decisive action in optimizing the investment portfolio.
- Core Holdings Retained: Despite the significant sell-off, Abel retained core holdings such as Apple, American Express, and Coca-Cola, reflecting his respect for and continuation of the company's traditional investment strategies established by Buffett.
- Positive Market Reaction: Following the announcement of Abel's investment strategy, Berkshire Hathaway's stock ticked higher, reflecting market confidence in his management capabilities and further solidifying the company's position in the investment community.
See More
Berkshire Hathaway's Abel Restructures Equity Portfolio
- Portfolio Restructuring: Greg Abel cut 16 small positions in the first quarter, including long-held Visa and Mastercard, demonstrating a strategic focus on concentrated high-conviction stocks while maintaining Buffett's traditional investment style.
- New Investment Directions: Abel added positions in Delta Airlines and Macy's, and tripled the investment in Alphabet, indicating a strategy aligned with Buffett's tech stock preferences, which may attract younger investors.
- Increased Concentration: Excluding investments in Japan, Berkshire now holds only 29 positions, retaining Buffett favorites like Apple, American Express, and Coca-Cola, reflecting ongoing confidence in classic quality assets.
- Positive Market Reaction: Despite the reduction of about one-third of the portfolio, Berkshire's stock price rose following the announcement, indicating market approval of Abel's investment strategy and suggesting optimistic expectations for future performance.
See More
Healthcare Stocks Surge Due to Innovation and Policy Changes
- Strong Sector Performance: The healthcare sector has shown remarkable performance, with the State Street Health Care Select Sector SPDR ETF (XLV) rising 3.3% over the past week, significantly outperforming the S&P 500's 0.5% gain, indicating a robust rebound and renewed investor confidence in healthcare stocks.
- Drug Innovation Driving Prices: Merck (MRK) saw a substantial stock price increase after announcing a lung cancer drug that reduced tumor progression risk by 65% in a Phase 3 study, highlighting the positive impact of ongoing pharmaceutical innovation on stock valuations.
- Favorable Medicare Policies: The Centers for Medicare and Medicaid Services announced that starting in 2027, Eli Lilly's (LLY) GLP-1 drugs will be available to Medicare patients for $50 a month, resulting in a 25% stock price increase for Lilly over three weeks, demonstrating the direct support of policy changes for healthcare stocks.
- Aging Population Trend: The global aging population is driving increased demand for pharmaceuticals, medical devices, and health insurance, positioning the healthcare sector as a focal point for investors seeking growth opportunities in the face of demographic shifts.
See More
Healthcare Sector Sees Best Week in Six Months
- Strong Sector Performance: The State Street Health Care Select Sector SPDR ETF (XLV) rose 3.3% over the past five trading days, significantly outperforming the S&P 500's 0.5% gain, establishing healthcare as the top-performing sector this week and reflecting strong investor confidence in the industry.
- Pharmaceutical Innovation: Merck (MRK) saw its stock rise 5.63% this week after announcing a 65% reduction in tumor progression risk from a lung cancer drug developed with a Chinese partner in a Phase 3 study, highlighting the ongoing innovation within the pharmaceutical sector.
- Favorable Insurance Policies: The Centers for Medicare and Medicaid Services announced that Eli Lilly's (LLY) GLP-1 drugs will be available to Medicare patients for $50 a month starting January 2027, leading to a 25% stock price increase for Lilly over three weeks, showcasing the positive impact of policy changes on company performance.
- Aging Population Trend: The global aging population is driving increased demand for pharmaceuticals and medical services, positioning the healthcare sector for robust growth and attracting investors to healthcare ETFs as a safer investment choice amid economic uncertainties.
See More
